Press Releases
2021
ImmunogenX and Mayo Clinic Successfully Complete the CeliacShield Trial (March 2021)
ImmunogenX Receives a Tibbetts Award (February 2021)
Further Latiglutenase Analyses Published in GastroHep (December 2019)
Jack A. Syage, CEO, Elected Fellow of the American Physical Society (August 2019)
National Institutes of Health (NIH) Awards Another Major Grant to ImmunogenX to Conduct a Clinical Trial for Latiglutenase (August 2019)
ImmunogenX Initiates Phase 2 Trial for its Lead Therapeutic and Diagnostic Candidates Latiglutenase and CypCel (March 2019)
ImmunogenX Completes CypCel Trial for Celiac Disease (September 2018)
AJCN Publication Garnering Tremendous Interest (March 2018)
NIH Awards Grant to ImmunogenX to Study Latiglutenase (October 2017)
Dr. Markku Mäki Joins the Scientific Advisory Board (October 2017)
New Latiglutenase Analyses Published in Digestive Disease & Science (August 2017)
ImmunogenX to Make Highlighted Presentations at DDW 2017 (January 2017)
Dr. Ciaran P. Kelly Joins the Scientific Advisory Board (January 2017)
ImmunogenX Invited to Present at the Medical Device & Investor Forum (November 2016)
ImmunogenX Invited to Present at the Pharmaceutical Strategy Conference (October 2016)
ImmunogenX Donates Patient Reported Outcome Instruments to
the Foundation for Celiac Disease Outcome Measures (May 2016)
ImmunogenX Acquires the Assets of Alvine Pharmaceuticals (March 2016)
ImmunogenX has closed a Class B overscribed investment round (October 2015)
ImmunogenX expands its Scientific Advisory Board (September 2015)
Detection of gluten in probiotics (May 2015)
In the News
2022
2021
Jennifer Sealey-Voyksner Special Guest for Beyond Celiac Blog Series (December 2021)
Significant Clinical Progress for Latiglutenase (May 2021)
Jennifer Sealey-Voyksner Chairs Session at Celiac Disease Foundation Summit (March 2021)
Matthew Dickason Featured on UC Irvine “Developing a Drug” Panel Discussion (February 2021)
2020
Jack Syage Selected to Orange County Business Journal OC 500 Directory of Influence (December 2020)
Jack Syage Featured Speaker at 2020 Celiac Disease Foundation Summit (February 2020)
ImmunogenX Featured Again in the Orange County Business Journal (February 2020)
New Phase 2 Clinical Trial for Symptomatic Celiac Disease Patients Launches (February 2020)
Potential Drug for Celiac Disease Improves Symptoms and Quality of Life in Some Patients (January 2020)
ImmunogenX is Featured in the Orange County Business Journal (September 2019)
ImmunogenX (50 Best Companies to Watch 2018: May 2018)
Dr. Jennifer Sealey Voyksner and Dr. Jack Syage speak at National Conference (Celiac Disease Foundation: May 5th, 2018)
The Dilemma of the Gluten-Free Diet (Wall Street Journal: April 16th, 2018)
When Going Gluten-Free Is Not Enough: New Tests Detect Hidden Exposure (NPR: April 3rd, 2018)
Gluten-Free Diet May Still Allow Harmful Levels of Exposure (Reuters: March 21st, 2018)
Celiac Disease Patients are Regularly Exposed to Unsafe Amounts of Gluten, Study Shows (Beyond Celiac: March 15, 2018)
Significant Study Published on the Amount of Gluten Eaten by Folks with Celiac Disease on a Gluten-Free Diet (Gluten-Free Watchdog: March 12, 2018)
Breaking Down Gluten to Treat Celiac Disease (Beyond Celiac: November 28th, 2017)
ImmunogenX Executives Interviewed (New York Stock Exchange: August 30th, 2017)
Update on Celiac Drug Designed to Support the Gluten-Free Diet (Allergic Living: July 26th, 2017)
ImmunogenX Donates Patient Reported Outcome Instruments to the Foundation for Celiac Disease Outcome Measures (Celiac Disease Foundation: June 2nd, 2016)
Many Probiotics Taken for Celiac Disease Contain Gluten (New York Times: May 19th, 2015)
Events
2022
19th International Celiac Disease Symposium (ICDS), October 19-22, 2022, Sorrento, Italy
- J. A. Syage, “Enzyme Therapy” (Invited Talk and Panel Discussion)
- J. A. Sealey-Voyksner, et al.: “Gluten in Urine Measurements Validate Latiglutenase Mechanism of Action in CeliacShield Gluten Challenge Study” (Poster)
- J. A. Syage, et al. “Considerations for a Composite Quantitative Histology Scale Based on Vh:Cd and IEL” (Poster)
BIO International Convention, June 13-16, San Diego, CA
- Jack Syage, “Breakthrough Treatments for Celiac Disease” (Invited Presentation)
Digestive Diseases Week (DDW), May 21-24 San Diego, CA
- J.A. Murray (Mayo), J. A. Syage, et al.: “CeliacShieldTM Gluten Challenge Study – Latiglutenase Protects the Mucosa and Attenuates Symptoms of Celiac Disease” (Invited Lecture Presentation)
- J. A. Sealey-Voyksner, et al.: “Gluten in Urine Measurements Validate Latiglutenase Mechanism of Action in CeliacShield Gluten Challenge Study” (Poster of Distinction and Poster Tour)
Celiac Disease, Where are the Patients and the Therapies?, April 8-9, 2022, Columbia University, NY
- Jennifer Sealey-Voyksner: “CeliacShieldTM Gluten Challenge Study” (Invited Talk)
2021
Life Sciences Summit 2021, Sponsored by the NIH, November 9-10, 2021
- Jack Syage, “Breakthrough Treatments for Celiac Disease,” (Invited Presentation)
United European Gastroenterology (UEG) Week Virtual 2021, October 3-5, 2021
- Jennifer Sealey-Voyksner, “CeliacShieldTM Gluten Challenge Study: Latiglutenase Protects the Mucosa and Attenuates Symptoms in Celiac Disease Patients” (Invited talk – UEG Research Prize 2021 Session)
19th International Celiac Disease Symposium (ICDS), October 14-17, 2021, Sorrento, Italy
- Jack Syage, “Title: TBD” (Distinguished Speaker)
Celiac Disease Foundation Patient Education & Advocacy Summit, March 4, 2021
- Jennifer Sealey-Voyksner, “Current State of Celiac Disease Diagnosis, Treatment, and Clinical Research” (Chair)
Tampere Celiac Disease Symposium 2020 – From Genomics to Personalized Health, September 18-19, 2020, Tampere University, Tampere, Finland
- J. A. Syage, et al.: “Latest Latiglutenase Clinical Trial Updates”
- J. Sealey-Voyksner, et al.: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients”
International Symposium – Celiac Disease, Now and the Future, March 6-7, 2020, Columbia University, NY
- Jack A. Syage: “Enzymes are Still in the Picture: the Case for Latiglutenase” (Invited Talk)
- Jennifer A. Sealey-Voyksner: “Gluten Detection in Food” (Invited Talk)
Celiac Disease Foundation Patient Advocacy Summit, February 27, 2020, Washington, CD
- Jack A. Syage: “Today and Tomorrow in Biopharmaceutical Research, Treatment and Cure” (Panel Talk)
Beyond Celiac Research Summit, November 14-15, 2019, Baltimore, MD
- Jennifer Sealey-Voyksner: “Getting Over the Peak: The Final Ascent to Realizing Therapies in Celiac Disease.” (panel member)
18th International Celiac Disease Symposium (ICDS) Sept 5-8, 2019, Paris, France
- J. A. Syage, P. H. R. Green, C. Khosla, D. C. Adelman, J. A. Sealey-Voyksner, J. A. Murray: “Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet”
- J. A. Sealey-Voyksner, J. A. Murray, C. Khosla, J. A. Syage: “Minimally-Invasive Monitoring of Intestinal Villous Health in Recovering Celiac Disease Patients”
IV International Conference on Urinomics and Translational Nephrology Sept 2-4, 2019, Caparica, Portugal
- J. A. Syage, C. P. Kelly, A. C. Cebolla Ramirez, F. Leon, R. Dominguez, J. A. Sealey-Voyksner: “Determination of Gluten Consumption in Celiac Disease Patients on a Gluten-Free Diet” (invited talk)
Digestive Diseases Week (DDW), May 18-22, San Diego, CA
- J. A. Syage, et al.: “Responder Analysis for Latiglutenase Reduction in Symptoms for Celiac Disease Patients”
- J. A. Sealey-Voyksner, et al.: “Minimally-Invasive Monitoring of Intestinal Villous Health in Recovering Celiac Disease Patients”
- J.A. Syage, et al.: “Latiglutenase Improves Quality of Life in Seropositive Celiac Disease Patients”
- A. C. Bledsoe, et al.: “Utility of Symptom Severity, Frequency, and Lability in Predicting Serology Status and Villous Injury in Symptomatic Adults with Treated Celiac Disease”
Tampere Celiac Disease Symposium 2018 – Serology and Biomarkers, September 13-15, 2018, University of Tampere, Tampere, Finland
- J. A. Syage, et al.: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients” (talk)
- J. A. Sealey-Voyksner, et al.: “Determination of Gluten Consumption by Celiac Disease Patients on a Gluten-Free Diet” (poster)
- J. A. Syage, et al.: “Correlation of Histologic and Symptomatic Response in a Celiac Trial for Latiglutenase” (poster)
Digestive Diseases Week (DDW), June 2-5, Washington, DC
- J. A. Syage, et al.: “Determination of Gluten Consumption by Celiac Disease Patients on a Gluten-Free Diet”
- J. A. Sealey-Voyksner, et al.: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients”
- J.A. Syage, et al.: “Correlation of Histologic, Serologic, and Symptomatic Measures of Celiac Disease Patients Participating in a Latiglutenase Clinical Trial”
Celiac Disease Foundation National Conference – Progress and Promise in the Treatment of Celiac Disease, May 4-5, 2018, Pasadena, CA
- Jennifer A. Sealey-Voyksner: “Living Gluten-Free to Live” (invited talk)
- Jack A. Syage: “Progress and Promise in the Treatment of Celiac Disease” (invited talk)
International Symposium – Celiac Disease, Now and the Future, March 1-3, 2018, Columbia University, NY
- Jack A. Syage: “Latiglutenase Really Works!” (invited talk)
- Jennifer A. Sealey-Voyksner: “Skip the ELISA: Liquid Chromatography-Mass Spectrometry” (invited talk)
Celiac Symposium, Nov 17, 2017, Stanford, CA
- J. Sealey-Voyksner: “Non-Dietary Therapies for Celiac Disease” (invited talk)
American Association of Pharmaceutical Scientists (AAPS) Nov 12-15, 2017, San Diego, CA
- J. Sealey-Voyksner, J. Murray, C. Khosla, J. Syage: “Monitoring Simvastatin Metabolism using LC/MS as a Diagnostic Tool for Celiac Disease Activity”
17th International Celiac Disease Symposium (ICDS) Sept 8-10, 2017, New Delhi, India
- J. A. Syage, J. A. Murray, Peter H. R. Green, J. A. Sealey-Voyksner, C. Khosla: “Latiglutenase Symptom Response for Seropositive vs. Seronegative Celiac Disease Patients” (talk)
- J. A. Sealey-Voyksner, J. A. Murray, M. Dickason, C. Khosla, J. A. Syage: “Simvastatin as a Biomarker for Intestinal Villous Health for Recovering Celiac Disease Patients” (talk)
- J. A. Syage, , P. T. Lavin, J. A. Sealey-Voyksner “Relationship Between Gluten Consumption and Symptom Severity for Celiac Disease Patients on a Gluten-Free Diet” (poster)
American Society of Mass Spectrometry (ASMS) Annual Meeting, June 4-8, 2017, Indianapolis, IN
- J. A. Sealey-Voyksner, J. A. Syage, J. A. Murray, C. Khosla: “Monitoring Simvastatin Metabolism using LC/MS as a Diagnostic Tool for Celiac Disease Activity”
Digestive Diseases Week (DDW), May 6-9, 2017, Chicago, IL
- Jack A. Syage: “Oral Latiglutenase Improves Chronic Symptoms in Seropositive Celiac Disease Patients” (Lecture Presentation)
- J. A. Syage, M. A. Dickason, J. A. Sealey-Voyksner: “Celiac Disease Patients Practicing a Gluten-Free Diet Still Consume Unsafe Levels of Gluten”
Biotech Showcase, Jan 9-11, 2017, San Francisco, CA
- Jack A. Syage: “Advanced Therapy and Diagnostic to Manage Celiac Disease”
Medical Devices Investment Forum, Oct 28, 2016, Newport Beach, CA
- Jack A. Syage: “Advanced Therapy and Diagnostic to Manage Celiac Disease” (invited talk)
Pharmaceutical Strategy Conference, Sept 28-30, 2016, New York, NY
- Jack A. Syage: “The Novel Use of Proprietary Enzymes for the Treatment of Celiac Disease” (invited talk)
AOAC Annual Meeting, Sept 18-21, 2016, Dallas, TX
- JA Sealey-Voyksner: “Towards a validated multiplexed LC-MS method for the detection of allergens and gluten in processed, fermented, hydrolyzed and distilled foods” (invited talk)
AOAC Annual Meeting, Sept. 27-30, 2015, Los Angeles, CA
- JA Sealey-Voyksner, J. Zeigenbaum, R. D. Voyksner: “Authenticity of Spice: Detection and Quantitation of Allergens”
- JA Sealey-Voyksner, J. Zeigenbaum, R. D. Voyksner: “Discovery of Unique Marker Peptides for Effective Detection of Soy and Wheat in Soy Sauce”
NACRW, July 19-22, 2015, St. Pete Beach, FL
- JA Sealey-Voyksner, J. Zeigenbaum, R. D. Voyksner: “Authenticity of Spice using LC/MS”
DDW 2015, May 16-19, Washington, DC
- S Nazareth, B Lebwohl, JA Sealey Voyksner and PHR Green: “Widespread Contamination of Probiotics with Gluten, Detected with Liquid Chromatography/Mass Spectrometry”
ASMS Annual Meeting, May 31-June 4, 2015, St. Louis, MO
MSACL 2015 Clinical Mass Spectrometry Conference, March 28-April 1, 2015, San Diego, CA
30th Montreux LC/MS Symposium – Food Allergens and Safety, Nov. 5-7, 2014, Charleston, SC, USA
- JA Syage, JA Sealey-Voyksner, C Khosla: “Metabolic Diagnostic for Celiac Disease Dietary Management by LC/MS” (invited talk)
- JA Sealey-Voyksner: “Multiplexed LC-MS assay for green plant-based allergens”
- ImmunogenX – Silver Sponsor
AACC International Annual Meeting, October 5-8, Providence, RI
- JA Sealey-Voyksner: “Gluten Detection and Quantitation in Food and Beverages Using a Multiplexed LC-MS Screening Method Based on Grain Specific Marker Peptides” (invited talk)
Separation Science Webinar – Advances in Food Safety Analysis, Sept 23, 2014
- JA Sealey-Voyksner: “Multiplexed LC-MS Screening Method for the Simultaneous Detection of Various Plant-Based Allergens and Gluten” (invited talk)
AOAC Annual Meeting, Sept. 7-10, 2014, Boca Raton, FL
- JA Sealey-Voyksner: “Qualitative and Quantitative Detection of Wheat, Barley and Rye Gluten in Beer by LC-MS” (invited talk)
- JA Sealey-Voyksner: “Towards the Validation of a new LC-MS Screening Method for the Simultaneous Detection and Quantitation of Multiple Plant-Based Allergens” (invited talk)
- JA Sealey-Voyksner: “The Discovery of Unique Marker Peptides for Detection of Trace Levels of Soy in Food Using LC/MS”
NACRW Annual Meeting, July 21-23, 2014, St. Pete, FL
- JA Sealey-Voyksner: “Moving Food Safety to Peptides- New Approaches using LC-MS for the Detection of Plant Allergens”
ASMS Annual Meeting, June 15-19, 2014, Baltimore, MD
- JA Sealey-Voyksner: “Simultaneous Screening of Multiple Plant-based Allergens and Gluten using Liquid Chromatography-Mass Spectrometry”
AOAC 33rd Annual Midwest Meeting, June 2-5, 2014, Oak Brook, IL
- JA Sealey-Voyksner: “LC-MS Screening Method for Multiple Plant-Based Allergens and Gluten” (invited talk)
8th Workshop on Food Allergens Methodologies, May 7, 2014, Vancouver, BC, Canada
- JA Sealey-Voyksner: “LC-MS Screening Method for Multiple Plant-Based Allergens and Gluten” (invited talk)
- JA Sealey-Voyksner: “Qualitative and Quantitative Detection of Wheat, Barley and Rye Gluten in Beer by LC-MS”
NASSCD: Therapies for Celiac Disease Conference, Mar. 20-21, 2014, Columbia University, NY
- JA Sealey-Voyksner: “Gluten Detection in the Food Chain” (invited talk)
MSACL 2014 Clinical Mass Spectrometry Conference, Mar. 1-5, 2014, San Diego, CA
- JA Syage, J Sealey-Voyksner, C. Khosla: “Non-invasive, in-situ screen for celiac disease management”
- JA Sealey-Voyksner: “Qualitative and Quantitative Detection of Plant-based allergens by LC-MS”